Aker BioMarine’s board of directors have received a proposal for a merger with wholly owned subsidiary Aker ASA for a merger, the company said.
The minority shareholders of Aker BioMarine will be offered consideration in the form of shares in Aker. The conversion ratio in the merger is based on an Aker BioMarine share price of NOK 1.2, which represents a premium of 17 percent to close on 11 September. Based on the proposed rate, Aker BioMarine shareholders will receive 0.0065 Aker ASA shares for each Aker BioMarine share owned.
The Aker BioMarine board is evaluating the proposal.
According to the company, chairman of the board Kjell Inge Rokke, has conflicted interests in the matter and will not participate in discussions.
